Resistance to Cefiderocol Involved Expression of PER-1 β-Lactamase and Downregulation of Iron Transporter System in Carbapenem-Resistant Acinetobacter baumannii
Yukun He,1,* Yifan Wang,1,* Xinqian Ma,1 Lili Zhao,1 Jie Guan,2 Jin Zhao,3 Wenyi Yu,1 Yanjun Li,4 Wentao Ni,1 Zhancheng Gao1 1Department of Pulmonary and Critical Care Medicine, Peking University People’s Hospital, Beijing, People’s Republic of China; 2Clinical Laboratory, Peking Uni...
Main Authors: | He Y, Wang Y, Ma X, Zhao L, Guan J, Zhao J, Yu W, Li Y, Ni W, Gao Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-12-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/resistance-to-cefiderocol-involved-expression-of-per-1--lactamase-and--peer-reviewed-fulltext-article-IDR |
Similar Items
-
Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysis
by: Christopher Longshaw, et al.
Published: (2023-12-01) -
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study
by: Davide Fiore Bavaro, et al.
Published: (2023-09-01) -
Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023-12-01) -
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study
by: Federica Calò, et al.
Published: (2023-09-01) -
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections
by: Amer El Ghali, et al.
Published: (2024-02-01)